Publications
138
Citations
5,236
Est. group size
~3
Recurring co-author estimate
Active years
51
Publishing since 1975
Michael P. Murphy conducts medical research focused on cardiovascular disease, including aortic aneurysms, peripheral artery disease, and heart failure. A significant portion of the work involves cell-based therapies (such as stem cells and cardiac progenitor cells) tested in clinical trials, along with studies on mitochondria-targeted treatments and disease mechanisms in animal and human models.
Publication activity peaked around 2017-2018, then declined mid-decade, with a modest recovery in recent years averaging about 4.4 papers per year.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Interactions between daily sleep-wake rhythms, γ-secretase, and amyloid-β peptide pathology point to complex underlying relationships
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025
- Maternal MitoQ Treatment Is Protective Against Programmed Alterations in CYP Activity Due to Antenatal Dexamethasone
Pharmaceutics · 2025
- Type 2 diabetes worsens the outcome of ischemia/reperfusion in female STEMI patients and female db/db mice with HFpEF cardiometabolic phenotype
medRxiv · 2025
- Effects of a highly hydrophilic mitochondria-targeted iron chelator
Free Radical Biology and Medicine · 2025
- Chronic hypoxia or MitoQ treatment in pregnancy independently alter hepatic cytochrome P450 activity in fetal sheep and 9-month-old lambs
Biochemical Pharmacology · 2025
- Exposure to Lead in Drinking Water Causes Cognitive Impairment via an Alzheimer’s Disease Gene-Dependent Mechanism in Adult Mice
Journal of Alzheimer s Disease · 2024
- A Phase <scp>II</scp> study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the <scp>CCTRN CONCERT‐HF</scp> trial
European Journal of Heart Failure · 2021
- Recommendations for nomenclature and definition of cell products intended for human cardiovascular use
Cardiovascular Research · 2021
- MicroRNASeq Target Analysis and Validation by Real-Time PCR in Abdominal Aortic Aneurysm
Proceedings of IMPRS · 2021
- Abstract 14080: A Phase II Randomized, Double-blind, Controlled Trial of Combined Mesenchymal Stromal Cells and C-kit+ Cardiac Progenitor Cells in Ischemic Heart Failure: The CCTRN CONCERT-HF Trial
Circulation · 2020
- Deletion of Socs3 Expression in Aortic Smooth Muscle Cells Ameliorates Aortic Dissection
JACC Basic to Translational Science · 2020
- A Phase I Study of Allogeneic Mesenchymal Stem Cell Therapy in Patients with Heart Failure Secondary to Anthracycline-induced Cardiomyopathy: The Cctrn Stem Cell Injection in Cancer Survivors (Seneca) Trial
Journal of Cardiac Failure · 2020
- Immune Modulation as a Treatment for Abdominal Aortic Aneurysms
Circulation Research · 2018
- IP231. Short- and Long-Term Outcomes After Abdominal Aortic Aneurysm Repair Are Noninferior at a Veterans Affairs Hospital Staffed by Academic Vascular Surgeons
Journal of Vascular Surgery · 2018
- Immune Modulation as a Treatment for Abdominal Aortic Aneurysms
PMC · 2018
- Journal of Vascular Surgery×24
- Annals of Vascular Surgery×9
- Proceedings of IMPRS×7
- Circulation×4
- Circulation Research×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile